Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.1

(5.48%)

FLWS

$3.72

(5.08%)

ACCO

$3.95

(23.05%)

ARLP

$26.15

(-1.73%)

AUIAF

$0.15

(0%)

AZZ

$143.53

(0.34%)

BTBT

$1.57

(3.97%)

BTM

$6.7

(0.45%)

CVKD

$6.35

(-4.8%)

LCE:CA

$0.37

(-2.63%)

COCP

$1.38

(-3.5%)

CDRO

$9.38

(3.19%)

CVGI

$4.15

(-0.72%)

LODE

$3.32

(1.22%)

CMTL

$3.68

(4.55%)

CNDT

$1.75

(2.34%)

CXW

$20.58

(0.59%)

CMLS

$0.01

(0%)

DRCT

$3.99

(34.34%)

DLHC

$5.76

(-1.03%)

SSP

$4.97

(3.76%)

ELDN

$3.69

(1.37%)

EVC

$3.83

(1.59%)

EDRY

$20.27

(3.84%)

ESEA

$70.57

(0.8%)

FAT

$0.16

(0%)

RAIL

$8.3

(0.73%)

GDEV

$16.46

(0.43%)

GOVX

$1.16

(5.96%)

GOCO

$1.11

(-1.77%)

GHM

$94.8

(-0.42%)

GLDD

$17

(0%)

GYRE

$7.58

(-1.88%)

HMENF

$2.18

(-0.91%)

III

$4.11

(0.74%)

IPOOF

$13.04

(0.23%)

KELYA

$9.65

(-1.13%)

KTOS

$62.05

(-1.59%)

LUCK

$7.81

(-1.76%)

MAIA

$1.34

(0.75%)

MGROF

$0.43

(-2.2%)

NTRB

$3.86

(-0.13%)

OCGN

$1.8

(4.05%)

PERF

$1.71

(3.01%)

QMCI

$0.16

(0%)

RGP

$4.39

(3.54%)

SGA

$11.01

(-2.39%)

SHWZ

(-99%)

SHIP

$15.47

(3.9%)

SLQT

$0.88

(-4.03%)

SKYX

$1.07

(-0.93%)

SNAL

$0.63

(-3.26%)

GEO

$18.75

(1.3%)

ODP

$28

(0%)

TNXP

$13.6

(5.18%)

TSQ

$6.52

(0.93%)

TZOO

$9.8

(0.1%)

UNCY

$7.67

(0.13%)

VVX

$67.74

(-0.1%)

VNCE

$4.91

(-1.6%)

XELB

$2.32

(8.74%)

ZOMDF

$0.1

(5.48%)

FLWS

$3.72

(5.08%)

channelchek-in

‌

5/1/2026

ARCHIMED to Take Esperion Therapeutics Private in Deal Valued at Up to $1.1 Billion

Esperion Therapeutics (Nasdaq: ESPR), the Ann Arbor-based commercial-stage biopharmaceutical company behind a growing portfolio of cardiometabolic therapies, is set to leave public markets after striking a definitive acquisition agreement with ARCHIMED, a Europe-headquartered healthcare-focused private equity firm with €9 billion in assets under management.

3 min read